Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 77,616 $ 171,089
Accounts receivable 7,132 13,291
Inventories, net 5,489 2,641
Deferred fulfillment costs (see Note 8 for related party transactions) 7,711 7,689
Prepaid expenses 4,947 5,138
Other current assets 7,113 5,078
Total current assets 110,008 204,926
Property and equipment - net 10,487 10,874
Operating lease right of use assets 7,710 0
Restricted cash 1,254 862
Other non-current assets 22 22
Total assets 129,481 216,684
Current liabilities:    
Accounts payable 8,774 6,766
Accrued expenses 9,180 15,659
Contract liabilities 14,875 19,216
Other current liabilities 1,017 146
Total current liabilities 33,846 41,787
Share-based compensation liability 3,335 15,435
Warrant liabilities 2,631 13,277
Operating lease liabilities, noncurrent 8,863 0
Other non-current liabilities 0 1,954
Total liabilities 48,675 72,453
Stockholders' equity (deficit):    
Common stock - Class A shares, $0.0001 par value; 385,000,000 shares authorized as of September 30, 2022 and December 31, 2021, 229,862,845 and 225,428,187 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively; Class C shares, par value $0.0001, 5,750,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021 24 24
Additional paid-in capital 465,355 449,307
Accumulated deficit (384,516) (305,084)
Accumulated other comprehensive (loss) (57) (16)
Total stockholders' equity 80,806 144,231
Total liabilities, mezzanine equity, and stockholders' equity $ 129,481 $ 216,684